Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin
- 24 February 2003
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (5) , 2420-2425
- https://doi.org/10.1073/pnas.0438031100
Abstract
Mismatch repair (MMR) proteins contribute to genome integrity by correcting replication errors. In higher eukaryotes, MMR proteins also regulate the cellular response to DNA lesions such as oxidized, alkylated, or crosslinked bases. Previous studies have linked MMR proteins to the activation of apoptosis through p53-dependent and p53-independent mechanisms. MMR-deficient cells exhibit variable defects in the induction of p53 and its related p73, which are activators of apoptosis. However, the specific role of each MMR protein in the regulation of apoptosis has not been determined. Here, we describe an interaction between PMS2, an MMR protein, and p73. This interaction causes the stabilization of p73 and the redistribution of PMS2 to the nuclear compartment. Exposure to cisplatin enhances the association between PMS2 and p73. Moreover, stimulation of the p73 proapoptotic function by cisplatin requires PMS2. These results suggest that PMS2 contributes to genome integrity not only through DNA repair but also by enhancing DNA damage-induced apoptosis.Keywords
This publication has 51 references indexed in Scilit:
- Meiotic arrest and aneuploidy in MLH3-deficient miceNature Genetics, 2002
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- Functional interactions and signaling properties of mammalian DNA mismatch repair proteinsCell Death & Differentiation, 2001
- 12/15-Lipoxygenase Translocation Enhances Site-specific Actin Polymerization in Macrophages Phagocytosing Apoptotic CellsJournal of Biological Chemistry, 2001
- Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 geneOncogene, 2000
- ATP-dependent Assembly of a Ternary Complex Consisting of a DNA Mismatch and the Yeast MSH2-MSH6 and MLH1-PMS1 Protein ComplexesPublished by Elsevier ,1998
- Drastic genetic instability of tumors and normal tissues in Turcot syndromeOncogene, 1997
- Enhancement of MSH2–MSH3-mediated mismatch recognition by the yeast MLH1–PMS1 complexCurrent Biology, 1997
- The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatinChemistry & Biology, 1996
- Clues to the Pathogenesis of Familial Colorectal CancerScience, 1993